Combination Cancer Therapy Image close
Combination Cancer Therapy on Hardback
Combination Cancer Therapy on Hardback
Show Hide Adult Content
Combination Cancer Therapy close

Non-Fiction Books:

Home  
Books  
Non-Fiction  
Professional & Technical  
Medicine  
Clinical & internal medicine  
Diseases & disorders  
Oncology

Combination Cancer Therapy

Modulators and Potentiators
Click to share your rating 0 ratings (0.0/5.0 average) Thanks for your vote!

Format:

Hardback
$416.99
RRP:
$455.95 save $38.96
Available from supplier

The item is brand new and in-stock with one of our preferred suppliers. The item will ship from a Mighty Ape warehouse within the timeframe shown.

Usually ships in 3-4 weeks
0 in Trolley

Buy Now, Pay Later with:

4 payments of $104.25 with Afterpay Learn more

Availability

Delivering to:

Estimated arrival:

  • Around 26 Jun - 8 Jul using International Courier

Explore more Cancer Drug Discovery and Development

See all products in this series

Farnesyltransferase Inhibitors in Cancer Therapy on Hardback Save $50
$404.99
$455.95
Farnesyltransferase Inhibitors in Cancer Therapy
Hardback
Available - Usually ships in 3-4 weeks
Checkpoint Controls and Targets in Cancer Therapy Save $13
$401.99
$415.95
Checkpoint Controls and Targets in Cancer Therapy
Paperback / softback
Available - Usually ships in 3-4 weeks
Hypoxia and Cancer on Hardback Save $10
$404.99
$415.95
Hypoxia and Cancer
Hardback
Available - Usually ships in 3-4 weeks
Macromolecular Anticancer Therapeutics on Hardback
$713.99
Macromolecular Anticancer Therapeutics
Hardback
Available - Usually ships in 3-4 weeks
Apoptosis and Cancer Chemotherapy Save $168
$286.99
$455.95
Apoptosis and Cancer Chemotherapy
Paperback / softback
Available - Usually ships in 3-4 weeks
Gene Therapy for Cancer on Hardback Save $36
$529.99
$566.95
Gene Therapy for Cancer
Hardback
Available - Usually ships in 3-4 weeks
DNA Topoisomerases and Cancer
$519.99
DNA Topoisomerases and Cancer
Paperback / softback
Available - Usually ships in 3-4 weeks
Nitric Oxide (NO) and Cancer on Hardback Save $153
$526.99
$680.95
Nitric Oxide (NO) and Cancer
Hardback
Available - Usually ships in 3-4 weeks
DNA Topoisomerases and Cancer on Hardback
$521.99
DNA Topoisomerases and Cancer
Hardback
Available - Usually ships in 3-4 weeks
Advances in DNA Repair in Cancer Therapy on Hardback
$518.99
Advances in DNA Repair in Cancer Therapy
Hardback
Available - Usually ships in 3-4 weeks
Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
$542.99
Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
Paperback / softback
Available - Usually ships in 3-4 weeks
COX-2 Blockade in Cancer Prevention and Therapy on Hardback Save $111
$409.99
$521.95
COX-2 Blockade in Cancer Prevention and Therapy
Hardback
Available - Usually ships in 3-4 weeks
PARP Inhibitors for Cancer Therapy on Hardback
$400.99
PARP Inhibitors for Cancer Therapy
Hardback
Available - Usually ships in 3-4 weeks
Checkpoint Controls and Targets in Cancer Therapy on Hardback Save $49
$406.99
$456.95
Checkpoint Controls and Targets in Cancer Therapy
Hardback
Available - Usually ships in 3-4 weeks
Innovations for Next-Generation Antibody-Drug Conjugates
$399.99
Innovations for Next-Generation Antibody-Drug Conjugates
Paperback / softback
Available - Usually ships in 3-4 weeks
Ex Vivo Engineering of the Tumor Microenvironment on Hardback
$397.99
Ex Vivo Engineering of the Tumor Microenvironment
Hardback
Available - Usually ships in 3-4 weeks

Description

Expert physician-scientists and clinicians review those combinations of novel target agents classic chemotherapies that hold the most promise for the future of medical oncology, and detail their optimal sequence, pharmacokinetic interactions, and interaction with downstream cellular signals. The combinations run the gamut of targeted therapies against cell surface receptors (EGF-R and HER2), the cell cycle (the CDKs), signal transduction events (PKC and NF-kB), apoptosis (bcl-2), as well as focused therapies in ovarian cancer, hematologic diseases, and breast cancer. The authors emphasize novel translational approaches that are rapidly moving from the laboratory bench top to the patient's bedside for the future treatments in caner therapy.
Release date Australia
December 3rd, 2004
Audience
  • Professional & Vocational
Contributor
  • Edited by Gary K Schwartz
Illustrations
X, 284 p.
Pages
284
Dimensions
155x235x17
ISBN-13
9781588292001
Product ID
3947618

Customer reviews

Nobody has reviewed this product yet. You could be the first!

Write a Review

Marketplace listings

There are no Marketplace listings available for this product currently.
Already own it? Create a free listing and pay just 9% commission when it sells!

Sell Yours Here

Recommended for you

Recommended from your browsing history

Help & options

Filed under...

Books >
Non-Fiction >
Professional & Technical >
Medicine >
Clinical & internal medicine >
Diseases & disorders >
Oncology